Romanelli Joseph 4
4 · Merck & Co., Inc. · Filed May 1, 2025
Insider Transaction Report
Form 4
Romanelli Joseph
President, Human Health Int?l
Transactions
- Award
Restricted Stock Unit
2025-04-29+9,444→ 9,444 totalFrom: 2026-04-29Exp: 2028-04-29→ Common Stock (9,444 underlying) - Award
Restricted Stock Unit
2025-04-29+4,722→ 4,722 totalFrom: 2026-04-29Exp: 2028-04-29→ Common Stock (4,722 underlying) - Award
Stock Option (Right to Buy)
2025-04-29+21,494→ 21,494 totalExercise: $84.71From: 2026-04-29Exp: 2035-04-28→ Common Stock (21,494 underlying)
Holdings
- 21,798.545
Common Stock
Footnotes (4)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F3]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
- [F4]The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.